| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Laboratory Medicine and Pathology [L. W., J. M. C., J. L. W., J. C. G., A. J. F., L. J. B., S. N. T.], Gastroenterology [L. A. B.], and Health Sciences Research [S. K. M., D. J. S.], Mayo Clinic and Foundation, Rochester, Minnesota 55905
Frequent BRAF mutations were reported recently in a variety of human malignancies, including colorectal cancer. In this study, we screened 293 colorectal cancers for mutations in exons 11 and 15, two regions containing hotspots for BRAF mutation. Of the 293 cancers, 170 had normal mismatch repair, and 123 had defective mismatch repair (originating from both somatic as well as germ-line mutations in several of the mismatch repair genes). A total of 63 exonic mutations (22%) were detected, 60 of which were V599E, and one each of D593G, G468E, and D586A. Of the tumors with defective mismatch repair, 34% (42 of 123) had a mutation in BRAF, whereas only 12% (21 of 170) of tumors with proficient mismatch repair demonstrated a mutation (P < 0.0001). Interestingly, BRAF mutations were found most often in cases with an hMHL1 abnormality (35 of 60) and rarely in cases with an hMSH2 abnormality (1 of 39; P < 0.0001). More interestingly, of the 31 hMLH1 cases with a BRAF mutation, 30 occurred in tumors known to have hypermethylation of hMLH1 promoter. Only 1 of the 15 cases with a germ-line mutation in hMLH1 had a mutation in BRAF. In this series, BRAF mutations occurred rarely in tumors with defective mismatch repair attributable to the presence of germ-line mutation in either hMLH1 or hMSH2. Furthermore, BRAF mutations were strongly associated with the epigenetic alteration of hMLH1. Overall, these data suggest that BRAF mutations are not a consequence of defective mismatch repair per se.
This article has been cited by other articles:
|
|
 |
|
  A. J. French, D. J. Sargent, L. J. Burgart, N. R. Foster, B. F. Kabat, R. Goldberg, L. Shepherd, H. E. Windschitl, and S. N. Thibodeau Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer Clin. Cancer Res., June 1, 2008; 14(11): 3408 - 3415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Crawford, D. Belajic, J. Wei, J. P. Riley, P. J. Dunford, S. Bembenek, A. Fourie, J. P. Edwards, L. Karlsson, A. Brunmark, et al. A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts, revealing IL-8 as a potential pharmacodynamic biomarker Mol. Cancer Ther., March 1, 2008; 7(3): 492 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Boardman, A. P. Lanier, A. J. French, K. V. Schowalter, L. J. Burgart, K. R. Koller, S. K. McDonnell, D. J. Schaid, and S. N. Thibodeau Frequency of Defective DNA Mismatch Repair in Colorectal Cancer among the Alaska Native People Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2344 - 2350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sanchez-de-Abajo, M. de la Hoya, M. van Puijenbroek, A. Tosar, J.A. Lopez-Asenjo, E. Diaz-Rubio, H. Morreau, and T. Caldes Molecular Analysis of Colorectal Cancer Tumors from Patients with Mismatch Repair Proficient Hereditary Nonpolyposis Colorectal Cancer Suggests Novel Carcinogenic Pathways Clin. Cancer Res., October 1, 2007; 13(19): 5729 - 5735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Svrcek, J. El-Bchiri, A. Chalastanis, E. Capel, S. Dumont, O. Buhard, C. Oliveira, R. Seruca, C. Bossard, J.-F. Mosnier, et al. Specific Clinical and Biological Features Characterize Inflammatory Bowel Disease Associated Colorectal Cancers Showing Microsatellite Instability J. Clin. Oncol., September 20, 2007; 25(27): 4231 - 4238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hao, V. M. Muniz-Medina, H. Mehta, N. E. Thomas, V. Khazak, C. J. Der, and J. M. Shields Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth Mol. Cancer Ther., August 1, 2007; 6(8): 2220 - 2229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bettstetter, S. Dechant, P. Ruemmele, M. Grabowski, G. Keller, E. Holinski-Feder, A. Hartmann, F. Hofstaedter, and W. Dietmaier Distinction of Hereditary Nonpolyposis Colorectal Cancer and Sporadic Microsatellite-Unstable Colorectal Cancer through Quantification of MLH1 Methylation by Real-time PCR Clin. Cancer Res., June 1, 2007; 13(11): 3221 - 3228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Maestro, M. Vidaurreta, M. T. Sanz-Casla, S. Rafael, S. Veganzones, A. Martinez, C. Aguilera, M. D. Herranz, J. Cerdan, and M. Arroyo Role of the BRAF Mutations in the Microsatellite Instability Genetic Pathway in Sporadic Colorectal Cancer Ann. Surg. Oncol., March 1, 2007; 14(3): 1229 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lagerstedt Robinson, T. Liu, J. Vandrovcova, B. Halvarsson, M. Clendenning, T. Frebourg, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, P. Peltomaki, et al. Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics J Natl Cancer Inst, February 21, 2007; 99(4): 291 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J J L Wong, N J Hawkins, and R L Ward Colorectal cancer: a model for epigenetic tumorigenesis Gut, January 1, 2007; 56(1): 140 - 148. [Full Text] [PDF]
|
|
|
|
|
|
J. Vandrovcova, K. Lagerstedt-Robinsson, L. Pahlman, and A. Lindblom Somatic BRAF-V600E Mutations in Familial Colorectal Cancer. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2270 - 2273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Lindor, G. M. Petersen, D. W. Hadley, A. Y. Kinney, S. Miesfeldt, K. H. Lu, P. Lynch, W. Burke, and N. Press Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA, September 27, 2006; 296(12): 1507 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.-J. Kim, H. C. Kang, S.-G. Jang, K. Kim, S.-A Ahn, H.-J. Yoon, S. N. Yoon, and J.-G. Park Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations Carcinogenesis, March 1, 2006; 27(3): 392 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Koinuma, R. Kaneda, M. Toyota, Y. Yamashita, S. Takada, Y. L. Choi, T. Wada, M. Okada, F. Konishi, H. Nagai, et al. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter Carcinogenesis, December 1, 2005; 26(12): 2078 - 2085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Llor, E. Pons, R. M. Xicola, A. Castells, C. Alenda, V. Pinol, M. Andreu, S. Castellvi-Bel, A. Paya, R. Jover, et al. Differential Features of Colorectal Cancers Fulfilling Amsterdam Criteria without Involvement of the Mutator Pathway Clin. Cancer Res., October 15, 2005; 11(20): 7304 - 7310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Samowitz, C. Sweeney, J. Herrick, H. Albertsen, T. R. Levin, M. A. Murtaugh, R. K. Wolff, and M. L. Slattery Poor Survival Associated with the BRAF V600E Mutation in Microsatellite-Stable Colon Cancers Cancer Res., July 15, 2005; 65(14): 6063 - 6069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Busby and A Morris Detection of BRAF mutations in colorectal tumours and peritoneal washings using a mismatch ligation assay J. Clin. Pathol., April 1, 2005; 58(4): 372 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Beach, A. O.-O. Chan, T.-T. Wu, J. A. White, J. S. Morris, S. Lunagomez, R. R. Broaddus, J.-P. J. Issa, S. R. Hamilton, and A. Rashid BRAF Mutations in Aberrant Crypt Foci and Hyperplastic Polyposis Am. J. Pathol., April 1, 2005; 166(4): 1069 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nagasaka, H. Sasamoto, K. Notohara, H. M. Cullings, M. Takeda, K. Kimura, T. Kambara, D. G. MacPhee, J. Young, B. A. Leggett, et al. Colorectal Cancer With Mutation in BRAF, KRAS, and Wild-Type With Respect to Both Oncogenes Showing Different Patterns of DNA Methylation J. Clin. Oncol., November 15, 2004; 22(22): 4584 - 4594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Oliveira, J. L. Westra, D. Arango, M. Ollikainen, E. Domingo, A. Ferreira, S. Velho, R. Niessen, K. Lagerstedt, P. Alhopuro, et al. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status Hum. Mol. Genet., October 1, 2004; 13(19): 2303 - 2311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Domingo, P Laiho, M Ollikainen, M Pinto, L Wang, A J French, J Westra, T Frebourg, E Espin, M Armengol, et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing J. Med. Genet., September 1, 2004; 41(9): 664 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Kambara, L A Simms, V L J Whitehall, K J Spring, C V A Wynter, M D Walsh, M A Barker, S Arnold, A McGivern, N Matsubara, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum Gut, August 1, 2004; 53(8): 1137 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Higuchi and J R Jass My approach to serrated polyps of the colorectum J. Clin. Pathol., July 1, 2004; 57(7): 682 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ikenoue, Y. Hikiba, F. Kanai, J. Aragaki, Y. Tanaka, J. Imamura, T. Imamura, M. Ohta, H. Ijichi, K. Tateishi, et al. Different Effects of Point Mutations within the B-Raf Glycine-Rich Loop in Colorectal Tumors on Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase and Nuclear Factor {kappa}B Pathway and Cellular Transformation Cancer Res., May 15, 2004; 64(10): 3428 - 3435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Konishi, T. Yamochi, R. Makino, K. Kaneko, T. Yamamoto, H. Nozawa, A. Katagiri, H. Ito, K. Nakayama, H. Ota, et al. Molecular Differences between Sporadic Serrated and Conventional Colorectal Adenomas Clin. Cancer Res., May 1, 2004; 10(9): 3082 - 3090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C V A Wynter, M D Walsh, T Higuchi, B A Leggett, J Young, and J R Jass Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer Gut, April 1, 2004; 53(4): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fransen, M. Klintenas, A. Osterstrom, J. Dimberg, H.-J. Monstein, and P. Soderkvist Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas Carcinogenesis, April 1, 2004; 25(4): 527 - 533. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
